申请人:Eli Lilly and Company
公开号:US04081458A1
公开(公告)日:1978-03-28
Compounds of the formula ##STR1## in which each R is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, hydroxy, cyano, or halo, and both R groups are identical and are symmetrically located; R.sub.1 is C.sub.1 -C.sub.3 alkyl and R.sub.2 is methyl, or R.sub.1 and R.sub.2 taken together are (CH.sub.2 --.sub.n in which n is an integer from 4 to 6; and (1) X.sub.c and X.sub.d are hydrogen, and the combination of X.sub.a and Y.sub.a and of X.sub.b and Y.sub.b each represents a double bond, subject to the limitation that, when R.sub.1 is C.sub.1 -C.sub.3 alkyl and is other than methyl, X.sub.c, X.sub.d, and R.sub.1 are all in an .alpha.-configuration; or (2) X.sub.a, X.sub.b, X.sub.c, X.sub.d, Y.sub.a, and Y.sub.b are hydrogen, subject to the limitation that both X.sub.c and X.sub.d are in an .alpha.-configuration, both X.sub.a and X.sub.b are in an .alpha.-configuration or in a .beta.-configuration, and, R.sub.1, when it is C.sub.1 -C.sub.3 alkyl, is in an .alpha.-configuration, are useful in inhibiting the action of androgens or are intermediates to such anti-androgen compounds.
公式为##STR1##的化合物,其中每个R是氢、C.sub.1 -C.sub.4烷基、C.sub.1 -C.sub.4氧烷基、羟基、氰基或卤素,且两个R基相同且对称排列;R.sub.1是C.sub.1 -C.sub.3烷基,R.sub.2是甲基,或者R.sub.1和R.sub.2一起取(CH.sub.2 --.sub.n,其中n是4到6的整数;以及(1)X.sub.c和X.sub.d是氢,X.sub.a和Y.sub.a的组合以及X.sub.b和Y.sub.b的组合分别表示双键,但限制条件是,当R.sub.1是C.sub.1 -C.sub.3烷基且不是甲基时,X.sub.c、X.sub.d和R.sub.1都处于α-构型;或者(2)X.sub.a、X.sub.b、X.sub.c、X.sub.d、Y.sub.a和Y.sub.b是氢,但限制条件是X.sub.c和X.sub.d都处于α-构型,X.sub.a和X.sub.b都处于α-构型或β-构型,且当R.sub.1是C.sub.1 -C.sub.3烷基时处于α-构型,这些化合物对抑制雄激素的作用有用,或者是这种抗雄激素化合物的中间体。